Csnk1d |
FASP & Migraine |
Candidate gene sequencing |
T44A and H46R |
Autosomal-dominant transmission; validation in in vitro and mice models |
PER2 |
FASP |
Linkage analysis and Candidate gene sequencing |
S662G |
Autosomal-dominant transmission; validation in in vitro and mice models |
PER3 |
FASP & SAD (seasonal affective disorder) |
Candidate gene sequencing |
P415A/H417R |
Autosomal-dominant transmission; validation in in vitro and mice models |
CRY2 |
FASP |
Candidate gene sequencing |
A260T |
Autosomal-dominant transmission; validation in in vitro and mice models |
DEC2 |
NSS |
Candidate gene sequencing |
P384R and Y362H |
Only P384R was tested in mice models. |
ABCC9 |
NSS |
GWAS |
rs11046205 A in intron |
Potentially affected the expression levels; not fully testified. |
PER3 |
EEG variations & SAD (seasonal affective disorder) |
polymorphism described in previous studies |
54-nucleotide variable number tandem repeat |
PER3(5/5) carriers showed increaseddelta activities in NREM sleep and a greater detrimental impact of sleep deprivation. |
ADA |
EEG variations &Multiple Sclerosis & Depression |
polymorphism described in previous studies |
D8N |
Carriers had deeper sleep and were under higher sleep pressure. |
ADORA2A |
EEG variations´ anxiogenic response to caffeine |
polymorphism described in previous studies |
polymorphisms at 3′ UTR |
Power in the high-theta/low-alpha range was invariably enhanced in the carriers in NREM, REM sleep, and wakefulness. Power in the waking EEG was higher in frequency bins between 11.5 – 17.5 Hz. |
BDNF |
EEG variations & autism spectrum disorders |
polymorphism described in previous studies |
V66M |
Carriers showed reduced SWS and decreased spectral power in specific bands at different stages of NREM sleep. |